Central nervous system metastases in women after multimodality therapy for high risk breast cancer

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Breast Cancer Research and Treatment

• Publication date

  2004-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s10549-004-0999-3PMID 15609130
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The distribution of systemically administered [3H]-paclitaxel in rats: a quantitative autoradiographic study

  2004cited by this paper
• Central nervous system metastases in women who receive trastuzumab‐based therapy for metastatic breast carcinoma

  2003cited by this paper
• Occult central nervous system involvement in patients with metastatic breast cancer: prevalence, predictive factors and impact on overall survival.

  2003cited by this paper
• Incidence of brain metastases in a cohort of patients with carcinoma of the breast, colon, kidney, and lung and melanoma

  2002cited by this paper
• Long-Term Outcome of Neoadjuvant Therapy for Locally Advanced Breast Carcinoma: Effective Clinical Downstaging Allows Breast Preservation and Predicts Outstanding Local Control and Survival

  2002cited by this paper
• Matrix metalloproteinases in neuroinflammation

  2002cited by this paper
• Revision of the American Joint Committee on Cancer staging system for breast cancer.

  2002cited by this paper
• Leptomeningeal Carcinomatosis after Major Remission to Taxane-based Front-line Therapy in Patients with Advanced Breast Cancer

  2002cited by this paper
• 2001 Highlights From: 37th Annual American Society of Clinical Oncology Meeting San Francisco, CA May 12–15, 2001

  2001cited by this paper
• High incidence of central nervous system involvement in patients with metastatic or locally advanced breast cancer treated with epirubicin and docetaxel.

  2001cited by this paper
• Highlights from: 37th Annual American Society of Clinical Oncology Meeting San Francisco, CA, May 12-15, 2001.

  2001cited by this paper
• Effect of adjuvant chemotherapy on outcome in patients with metastatic breast carcinoma treated with first‐line doxorubicin‐containing chemotherapy

  2001cited by this paper
• Preoperative chemotherapy in patients with operable breast cancer: nine-year results from National Surgical Adjuvant Breast and Bowel Project B-18.

  2001cited by this paper
• Weekly trastuzumab and paclitaxel therapy for metastatic breast cancer with analysis of efficacy by HER2 immunophenotype and gene amplification.

  2001cited by this paper
• Trastuzumab in CSF.

  2000cited by this paper
• Patterns of disease spread in metastatic breast carcinoma: influence of estrogen and progesterone receptor status.

  2000cited by this paper
• Incidence and impact of documented eradication of breast cancer axillary lymph node metastases before surgery in patients treated with neoadjuvant chemotherapy.

  1999cited by this paper
• Central nervous system progression of metastatic breast cancer in patients treated with paclitaxel

  1995cited by this paper
• Brain metastases in breast cancer; natural history, prognostic factors and outcome

  1993cited by this paper
• Influence of age on the metastatic behavior of breast carcinoma.

  1988cited by this paper
• The effect of prior adjuvant chemotherapy on survival in metastatic breast cancer

  1988cited by this paper
• The pattern of metastases in human breast cancer. Influence of systemic adjuvant therapy and impact on survival.

  1988cited by this paper
• Survival from first recurrence: relative importance of prognostic factors in 1,015 breast cancer patients.

  1987cited by this paper
• Central nervous system metastasis from breast carcinoma autopsy study

  1983cited by this paper
• Brain metastases in breast cancer patients receiving adjuvant chemotherapy

  1982cited by this paper
• Oestrogen receptors, sites of metastatic disease and survival in recurrent breast cancer.

  1981cited by this paper
• Intracerebral metastases in solid‐tumor patients: Natural history and results of treatment

  1981cited by this paper
• Causes of death in breast cancer a clinicopathologic study

  1980cited by this paper
• The natural history of breast cancer patients with brain metastases

  1979cited by this paper
• An autopsy study of metastatic sites of breast cancer.

  1973cited by this paper

• Carmustine Wafers (Gliadel) in Brain Metastases: Revisiting an Old Concept With New Insights

  2025cites this paper
• Rare report of concurrent metastasis on bilateral atrial myxoma masses

  2021cites this paper
• Assessment of Pathological Features and Molecular Profiling of Triple-Negative Breast Cancer: A Retrospective Study at King Abdulaziz University Hospital, Jeddah, Saudi Arabia

  2020cites this paper
• Inhibition of miR-155, a therapeutic target for breast cancer, prevented in cancer stem cell formation

  2017cites this paper
• Clinicopathological features of early failure of neoadjuvant chemotherapy in locally advanced breast cancer

  2014cites this paper
• Comparative analysis of survival, treatment, cost and resource use among patients newly diagnosed with brain metastasis by initial primary cancer

  2013cites this paper
• Development of a Preclinical Therapeutic Model of Human Brain Metastasis with Chemoradiotherapy

  2013cites this paper
• Gliadel for brain metastasis

  2013cites this paper
• Immunohistochemical prediction of brain metastases in patients with advanced breast cancer: the role of Rad51.

  2013cites this paper
• Cisplatin plus gemcitabine for treatment of breast cancer patients with brain metastases; a preferential option for triple negative patients?

  2013cites this paper
• The European Society of Breast Cancer Specialists recommendations for the management of young women with breast cancer.

  2012cites this paper
• Incidence of brain metastases as a first site of recurrence among women with triple receptor–negative breast cancer

  2012cites this paper
• Clinicopathologic features and prognosis of triple-negative breast cancer in patients 40 years of age and younger in Saudi Arabia.

  2012cites this paper
• The factors that have an impact on the development of brain metastasis in the patients with breast cancer.

  2012cites this paper
• Challenging the current paradigm of melanoma progression: brain metastasis as isolated first visceral site.

  2012cites this paper
• Breast Cancer Therapies Present and Future

  2012cites this paper
• The EUSOMA recommendations for the management of young women with breast cancer

  2012cites this paper
• Incidence of brain metastases in early stage HER2 3+ breast cancer patients; is there a role for brain CT in asymptomatic patients?

  2012cites this paper
• [Prevention strategies for brain metastases from HER2-positive breast cancer].

  2011cites this paper
• Trends in Survival After Surgery for Breast Cancer Metastatic to the Brain and Spinal Column in Medicare Patients: A Population-Based Analysis

  2011cites this paper
• Expression of endoplasmic reticulum stress proteins is a candidate marker of brain metastasis in both ErbB-2+ and ErbB-2- primary breast tumors.

  2011cites this paper
• Cerebral metastases in metastatic breast cancer: disease-specific risk factors and survival.

  2011cites this paper
• Inflammatory mammary carcinoma with metastasis to the brain and distant organs in a spayed Shih Tzu dog

  2011cites this paper
• A subset of breast cancer predisposes to brain metastasis

  2011cites this paper
• Breast carcinoma with brain metastases: clinical analysis and immunoprofile on tissue microarrays.

  2011cites this paper
• Translational research in brain metastasis is identifying molecular pathways that may lead to the development of new therapeutic strategies.

  2010cites this paper
• Brain metastases in HER2-positive breast cancer: the evolving role of lapatinib.

  2010cites this paper
• A Case of Brain Metastases from Breast Cancer that Responded to Anastrozole Monotherapy

  2009cites this paper
• The role of intra-cerebrospinal fluid treatment and prophylaxis in patients with solid tumors.

  2009cites this paper
• Human epidermal growth factor receptor 2-positive breast cancer and central nervous system metastases.

  2009cites this paper
• Identification of patients who may benefit from the prophylactic cranial radiotherapy among breast cancer patients with brain metastasis

  2009cites this paper
• Triple-negative and HER2-overexpressing breast cancers exhibit an elevated risk and an earlier occurrence of cerebral metastases.

  2009cites this paper
• Brain Metastases Secondary to Breast Cancer: Symptoms, Prognosis and Evolution

  2009cites this paper
• Analyses of Resected Human Brain Metastases of Breast Cancer Reveal the Association between Up-Regulation of Hexokinase 2 and Poor Prognosis

  2009cites this paper
• Is risk of central nervous system (CNS) relapse related to adjuvant taxane treatment in node-positive breast cancer? Results of the CNS substudy in the intergroup Phase III BIG 02-98 Trial.

  2008cites this paper
• Preliminary characterization of an experimental breast cancer cells brain metastasis mouse model by MRI/MRS

  2008cites this paper
• Effect of lapatinib on the outgrowth of metastatic breast cancer cells to the brain.

  2008cites this paper
• Factors affecting the prognosis of breast cancer patients with brain metastases.

  2008cites this paper
• Biological pathways contributing to organ-specific phenotype of brain metastatic cells.

  2008cites this paper
• Is there a qualitative interaction between adjuvant trastuzumab and size of the primary tumor in breast cancer?

  2008cites this paper
• Her-2 overexpression increases the metastatic outgrowth of breast cancer cells in the brain.

  2007cites this paper
• Treatment of Single Brain Metastasis with Resection, Intracavity Carmustine Polymer Wafers, and Radiation Therapy Is Safe and Provides Excellent Local Control

  2007cites this paper
• Optic neuritis in evolution.

  2007cites this paper
• Brain Metastases of Breast Cancer

  2007cites this paper
• Brain Metastases: The HER2 Paradigm

  2007cites this paper
• Challenges of Brain Metastasis in ErbB2 (HER-2-positive) Breast Cancer and the Potential of Small Molecules

  2007cites this paper
• Management of neurological complications in metastatic breast cancer

  2006cites this paper
• Systemische Chemotherapie beim metastasierten Mammakarzinom

  2006cites this paper
• Primary and secondary tumours occurring simultaneously in the brain of a dog.

  2006cites this paper
• Primary breast cancer phenotypes associated with propensity for central nervous system metastases

  2006cites this paper
• An era of rapid advancement: diagnosis and treatment of metastatic brain cancer.

  2005cites this paper
• Current Treatment Paradigms for the Management of Patients with Brain Metastases

  2005cites this paper
• Brain metastases of breast cancer

  2005cites this paper
• Possible role of CXCR4-mediated chemotaxis in breast cancer patients with central nervous system metastases

  2005cites this paper